AI
Ainos, Inc.
AIMDW · NASDAQ
$0.08 -1.30% (-$0.00)
1M -19.66%
Market Cap $362.7K
P/E Ratio -
Div. Yield -
ROE 217.50%
Bulios Fair Price
$0.11
44.7% upside
Current Price
$0.076
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AIMDW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/S 26.67x
P/B 0.11x
P/E N/A
Growth
0 /100
Declining Rev. growth 67.20%
Book val. growth 39.78%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 34,987.50%
Net margin 106,283.00%
Op. margin 101,210.00%
Quality
0 /100
Poor ROIC 80.51%
ROE 217.50%
ROA 73.89%
Debt
0 /100
High Debt/Equity 4.21x
Current ratio 0.13x
Int. coverage -18.79x
Stability
1 /100
Unstable Beta 2.17x
Rev. volatility 339.97%
EPS volatility 96.25%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AIMDW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chun-Hsien Tsai
Employees
41
Headquarters
Houston